Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History | Funding Information
International Journal of Diabetes & Clinical Diagnosis Volume 3 (2016), Article ID 3:IJDCD-120, 3 pages
http://dx.doi.org/10.15344/2394-1499/2016/120
Commentary
Heat Shock Gene Sirtuin 1 Regulates Post-Prandial Lipid Metabolism with Relevance to Nutrition and Appetite Regulation in Diabetes

Ian James Martins

1Centre of Excellence in Alzheimer’s Disease Research and Care, School of Medical Sciences, , Edith Cowan University, 270 Joondalup Drive, Joondalup, 6027, Australia
2School of Psychiatry and Clinical Neurosciences, The University of Western Australia, Nedlands, 6009,Australia
3McCusker Alzheimer's Research Foundation, Holywood Medical Centre, 85 Monash Avenue, Suite 22, Nedlands, 6009, Australia
Dr. Ian James Martins, School of Medical Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, Western Australia 6027, Australia, Tel: +61863042574; E-mail: i.martins@ecu.edu.au
15 September 2016; 01 November 2016; 03 November 2016
Martins IJ (2016) Heat Shock Gene Sirtuin 1 Regulates Post-Prandial Lipid Metabolism with Relevance to Nutrition and Appetite Regulation in Diabetes. Int J Diabetes Clin Diagn 3: 120. doi: http://dx.doi.org/10.15344/2394-1499/2016/120
This work was supported by grants from Edith Cowan University, the McCusker Alzheimer's Research Foundation and the National Health and Medical Research Council.
© 2016 Martins. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, et al. (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64: 73-84. View
  2. Martins IJ (2014) Induction of NAFLD with Increased Risk of Obesity and Chronic Diseases in Developed Countries. Open J Endocr Metab Dis 4: 90-110. View
  3. Martins IJ (2016) Type 3 diabetes with links to NAFLD and Other Chronic Diseases in the Western World. International J Diab 1: 1-5. View
  4. Chehade JM, Gladysz M, Mooradian AD (2013) Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs 73: 327- 339. View
  5. Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P4, et al. (2014) Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. J Am Coll Cardiol 64: 485-494. View
  6. Martins IJ (2016) Diet and Nutrition reverse Type 3 Diabetes and Accelerated Aging linked to Global chronic diseases. J Diab Res Ther 2. View
  7. Liang Q, Zhong L, Zhang J, Wang Y, Bornstein SR, et al. (2014) FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting. Diabetes 63: 4064-4075. View
  8. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E, et al. (2007) SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6: 759-767. View
  9. Xu F, Gao Z, Zhang J, Rivera CA, Yin J, et al. (2010) Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation. Endocrinology 151: 2504- 2514. View
  10. Purushotham A, Xu Q, Li X (2012) Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding. FASEB J 26: 656-667. View
  11. Tomita T, Hamazaki J, Hirayama S, McBurney MW, Yashiroda H, et al. (2015) Sirt1-deficiency causes defective protein quality control. Sci Rep 5: 12613. View
  12. Rensing L, Monnerjahn C (1996) Heat shock proteins and circadian rhythms. Chronobiol Int 13: 239-250. View
  13. Kakimura J, Kitamura Y, Takata K, Umeki M, Suzuki S, et al. (2002) Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J 16: 601-603. View
  14. Wilhelmus MM, de Waal RM, Verbeek MM (2007) Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease. Mol Neurobiol 35: 203-216. View
  15. Martins IJ (2015) Diabetes and Cholesterol Dyshomeostasis Involve Abnormal a-Synuclein and Amyloid Beta Transport in Neurodegenerative Diseases. Austin Alzheimers J Parkinsons Dis 2: 1020-28. View
  16. Ariesandi W, Chang CF, Chen TE, Chen YR (2013) Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of preexisting oligomers in alpha-synuclein fibrillization. PLoS One 8: e53487. View
  17. Ghavami M, Rezaei M, Ejtehadi R, Lotfi M, Sokargozar MA, et al. (2013) Physiological Temperature Has a Crucial Role in Amyloid Beta in theAbsence and Presence of Hydrophobic and Hydrophilic Nanoparticles. ACS Chem Neurosci 4: 375-378. View
  18. Martins IJ (2015) Unhealthy Nutrigenomic Diets Accelerate NAFLD and Adiposity in Global communities. J Mol Genet Med 9: 1-11. View
  19. Tang BL (2016) Sirt1 and the Mitochondria. Mol Cells 39: 87-95. View
  20. Malhi H, Kaufman RJ (2011) Endoplasmic reticulum stress in liver disease. J Hepatol 54: 795-809. View
  21. Ashraf NU, Sheikh TA (2015) Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. Free Radic Res 49: 1405-1418. View
  22. Bravo R, Gutierrez T, Paredes F, Gatica D, Rodriguez AE, et al. (2012) Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics. Int J Biochem Cell Biol 44: 16-20. View
  23. Amat R, Planavila A, Chen SL, Iglesias R, Giralt M, et al. (2009) SIRT1 controls the transcription of the peroxisome proliferator-activated receptorgamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J Biol Chem 284: 21872-21880. View
  24. Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P (2008) Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett 582: 46-53. View
  25. Cantó C, Auwerx J (2009) PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 20: 98-105. View
  26. Higashida K, Kim SH, Jung SR, Asaka M, Holloszy JO, et al. (2013) Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation. PLoS Biol 11: e1001603. View
  27. Cornu M, Oppliger W, Albert V, Robitaille AM, Trapani F, et al. (2014) Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21. Proc Natl Acad Sci U S A 111: 11592-11599. View
  28. Ghosh HS, McBurney M, Robbins PD (2010) SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One 5: e9199. View
  29. Huang J, Dibble CC, Matsuzaki M, Manning BD (2008) The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 28: 4104-4115. View
  30. Martins IJ (2016) Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations. Advances in Aging Research 5: 9-26. View
  31. Kuro-o M (2009) Klotho and aging. Biochim Biophys Acta 1790: 1049-1058. View
  32. Yan H, Jihong Y, Feng Z, Xiaomei X, Xiaohan Z, et al. (2014) Sirtuin 1-mediated inhibition of p66shc expression alleviates liver ischemia/ reperfusion injury. Crit Care Med 42: e373-381. View
  33. Haga S, Morita N, IraniK, Fujiyoshi, M, et al (2010) p66Shc has a pivotal function in impaired liver regeneration in aged mice by a redox-dependent mechanism. Special Issue – Hepatic and Pancreatic Systems. Lab Invest 90: 1718–1726. View
  34. Carbajo-Pescador S, Mauriz JL, García-Palomo A, González-Gallego J1 (2014) FoxO proteins: regulation and molecular targets in liver cancer. Curr Med Chem 21: 1231-1246. View
  35. Tikhanovich I, Cox J, Weinman SA (2013) Forkhead box class O transcription factors in liver function and disease. J Gastroenterol Hepatol 28 Suppl 1: 125-131. View
  36. Martins IJ (2016) The role of Clinical Proteomics, Lipidomics and Genomics in the diagnosis of Alzheimer’s disease. Proteome 4: 1-19. View
  37. Martins IJ (2016) Magnesium Therapy Prevents Senescence with the Reversal of Diabetes and Alzheimer’s Disease. Health 8: 694-710. View
  38. Zhu S, Wu Y, Ye X, Ma L, et al. (2016) FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy. Mol Cell Biochem 420: 107-119. View
  39. Domouzoglou EM, Naka KK, Vlahos AP, Papafaklis MI, Michalis LK, et al. (2015) Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21. Am J Physiol Heart Circ Physiol 309: H1029-1038. View
  40. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, et al. (2013) MicroRNA- 34a regulates cardiac ageing and function. Nature 495: 107-110. View
  41. Shang W, Yu X, Wang H, Chen T, Fang Y, et al. (2015) Fibroblast growth factor 21 enhances cholesterol efflux in THP-1 macrophage-derived foam cells. Mol Med Rep 11: 503-508. View
  42. Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, et al. (2008) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57: 1246-1253. View
  43. So WY, Leung PS1 (2016) Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus. Med Res Rev 36: 672-704. View
  44. Qiao L, Yoo Hs, Bosco C, Lee B, Feng GS, et al. (2014) Adiponectin reduces thermogenesis by inhibiting brown adipose tissue activation in mice. Diabetologia 57: 1027-1036. View
  45. Martins IJ (2016) Bacterial Lipopolysaccharides Change Membrane Fluidity with Relevance to Phospholipid and Amyloid Beta Dynamics in Alzheimer’s Disease. J Microb Biochem Technol. 8: 322-324. View
  46. Martins IJ (2015) Diabetes and Organ Dysfunction in the Developing and Developed. Global J of Med Res F Diseases 15: 1-6. View
  47. Martins IJ (2013) Increased Risk for Obesity and Diabetes with Neurodegeneration in Developing Countries. J Mol Genet Med S1: 1-8. View
  48. Martins IJ (2015) Nutritional diets accelerate amyloid beta metabolism and prevent the induction of chronic diseases and Alzheimer’s disease. Photon ebooks. 1-48. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.